Algorithmics charts new course in year-plus after SS&C acquisition

After eight years with IBM, Algorithmics has grown its staff significantly in the year since SS&C bought the risk analytics provider. The vendor is now taking aim at tapping into SS&C’s roster of buy-side users by embedding with the likes of Advent and Eze Software.

Algorithmics, which started doing business in 1989, has known relative stability in its product line, establishing its bona fides in the realms of market risk analytics and regulatory services. It’s on the M&A front that the changes have occurred.

In the 21st century, the vendor has been acquired three times. At the start of 2005, Fitch Group bought Algorithmics for $175 million. Then, in late 2011, it was tech behemoth IBM acquiring Algorithmics for about $380 million. That pairing was also

Only users who have a paid subscription or are part of a corporate subscription are able to print or copy content.

To access these options, along with all other subscription benefits, please contact info@waterstechnology.com or view our subscription options here: http://subscriptions.waterstechnology.com/subscribe

You are currently unable to copy this content. Please contact info@waterstechnology.com to find out more.

Sorry, our subscription options are not loading right now

Please try again later. Get in touch with our customer services team if this issue persists.

New to Waterstechnology? View our subscription options

Register for free

Access two articles, our IMD and Waters Wraps, plus a member newsletter. Find out more.

All fields are mandatory unless otherwise highlighted.

Removal of Chevron spells t-r-o-u-b-l-e for the C-A-T

Citadel Securities and the American Securities Association are suing the SEC to limit the Consolidated Audit Trail, and their case may be aided by the removal of a key piece of the agency’s legislative power earlier this year.

Most read articles loading...

You need to sign in to use this feature. If you don’t have a WatersTechnology account, please register for a trial.

Sign in
You are currently on corporate access.

To use this feature you will need an individual account. If you have one already please sign in.

Sign in.

Alternatively you can request an individual account here